We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Says Nonopioid Analgesics May Qualify for Expedited Review
FDA Says Nonopioid Analgesics May Qualify for Expedited Review
Drug companies with a candidate nonopioid analgesic should consider applying for expedited review through FDA’s special approval pathways, according to new draft guidance released yesterday.